Company Overview

Company name: Eviana Health (CNQ: EHC)
Description: Developer of cannabinoid-based topical creams and products created to promote wellness through a chemical free method. The company’s products include customized consumer health-care products, pharmaceuticals, nutraceuticals, and cosmeceuticals, enabling its clients to use organic, sustainable hemp based pharmaceutical products.
Year founded: 2011
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.eviana.ca
Employees:
City: Vancouver
State: British Columbia
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue/Not Profitable
Ownership: Publicly Held
Exchange: CNQ
Ticker: EHC
Revenue (USD Million): 0.00
Gross profit (USD Million): -0.04
Net income (USD Million) -3.81
Enterprise value: 16.82
Earnings before interest, tax, depreciation and amortization (EBITDA): -3.66
Fiscal period: FY 2018
Financing Status: A 40% stake in the company (CSE: EHC) was acquired by Organigram Holdings (TSX: OGI) for CAD 10 million on October 2, 2018.
Number of active investors:
Profile last updated: 04-Oct-2018
Last known valuation: 19.18
Last known valuation date: 02-Oct-2018